Toluene-2,4-diisocyanate
|
CAS
584-84-9
|
CH3C6H3(NCO)2
|
RTECS
CZ6300000
|
Synonyms & Trade Names
TDI; 2,4-TDI; 2,4-Toluene diisocyanate
|
DOT ID & Guide
2078 / 156
|
Exposure
Limits
|
NIOSH REL: Ca See Appendix A
|
|
OSHA PEL†: C 0.02 ppm (0.14 mg/m3)
|
IDLH
Ca [2.5 ppm]
See: 584849
|
Conversion
1 ppm = 7.13 mg/m3
|
Physical Description
Colorless to pale-yellow solid or liquid (above 71°F) with a sharp, pungent odor.
|
MW: 174.2
|
BP: 484°F
|
MLT: 71°F
|
Sol: Insoluble
|
VP(77°F): 0.01 mmHg
|
IP: ?
|
|
Sp.Gr: 1.22
|
Fl.P: 260°F
|
UEL: 9.5%
|
LEL: 0.9%
|
|
|
Class IIIB Combustible Liquid: Fl.P. at or above 200°F.
|
Incompatibilities & Reactivities
Strong oxidizers, water, acids, bases & amines (may cause foam & spatter); alcohols [Note: Reacts slowly with water to form carbon dioxide and polyureas.]
|
Measurement Methods
NIOSH 2535, 5521, 5522, 5525;OSHA 18, 33, 42
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated/Daily
Remove: When wet or contaminated
Change: Daily
Provide: Eyewash, Quick drench
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Soap wash immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations
NIOSH
At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration:
(APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure- demand or other positive-pressure mode
(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape:
(APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
|
Exposure Routes
inhalation, ingestion, skin and/or eye contact
|
Symptoms
Irritation eyes, skin, nose, throat; choke, paroxysmal cough; chest pain, retrosternal (occurring behind the sternum) soreness; nausea, vomiting, abdominal pain; bronchitis, bronchospasm, pulmonary edema; dyspnea (breathing difficulty), asthma; conjunctivitis, lacrimation (discharge of tears); dermatitis, skin sensitization; [potential occupational carcinogen]
|
Target Organs
Eyes, skin, respiratory system
Cancer Site
[in animals: pancreas, liver, mammary gland, circulatory system & skin tumors]
|
|
See also: INTRODUCTION
See ICSC CARD: 0339 See MEDICAL TESTS: 0233
|
